Farooq Saleem
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Farooq Saleem has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Muhammad Usman Mirza
University of Windsor
2 shared publications - Sarfraz Ahmad
University of Windsor
2 shared publications - Arshad Ali Shah
University of Lahore
1 shared publication - Imran Waheed
Akhtar Saeed College of Pharmaceutical Sciences, Bahria Town, Lahore 54000, Pakistan
1 shared publication - Iskandar Abdullah
University of Malaya
1 shared publication - John Frederick Trant
University of Windsor 401 Sunset Avenue
1 shared publication
Latest Publications
- Open Access
- 14 October 2025
- Published by American Chemical Society (ACS) in ChemRxiv
First identification of trigonelline in Guaiacum Officinale fruit and its dengue protease inhibition activity
Although Dengue virus (DENV) continues to cause substantial global morbidity, no direct-acting antivirals are available for routine clinical use despite the viral NS2B–NS3 serine protease being a well-validated enzymatic target for small-molecule inhibition. Here we report, to our knowledge, the first identification (and HPLC quantification) of trigonelline (N-methylnicotinic acid) in Guaiacum officinale fruit and demonstrate its inhibition of the DENV-2 NS2B–NS3 protease (IC₅₀ = 76±3 μM). To explain this activity, we integrated unbiased molecular docking with molecular dynamics (MD) and end-point calculations. The MD-relaxed binding mode places the trigonelline carboxylate in a polar niche stabilized by a Ser135 and Tyr150 hydrogen-bond dyad, while the pyridinium ring engages an adjacent aromatic shelf (Tyr161 and Phe130) near the His51–Asp75–Ser135 catalytic triad. The low protein RMSD and low ligand drift suggest this is a persistent pose. MM/GBSA calculated affinity is dominated by van der Waals contributions, and a per-residue decomposition highlight stabilizing roles for Ser135, Tyr150, and Pro132, consistent with the observed contact pattern and supportive of target engagement. While the potency is moderate, it is consistent with a fragment-like chemotype in the protease substrate-binding cleft and provides a tractable entry point for derivatization. Contact-persistence and the energy decomposition suggest promising avenues for future structure–activity exploration, i.e., extension of the ligand into the S1/S2 subsites, reinforcement of aromatic contacts, and polarity management to increase hydrophobic collapse as a new opportunity for dengue protease inhibitor design.
- 14 October 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessFirst identification of trigonelline in Guaiacum Officinale fruit and its dengue protease inhibition activity
Although Dengue virus (DENV) continues to cause substantial global morbidity, no direct-acting antivirals are available for routine clinical use despite the viral NS2B–NS3 serine protease being a well-validated enzymatic target for small-molecule inhibition. Here we report, to our knowledge, the first identification (and HPLC quantification) of trigonelline (N-methylnicotinic acid) in Guaiacum officinale fruit and demonstrate its inhibition of the DENV-2 NS2B–NS3 protease (IC₅₀ = 76±3 μM). To explain this activity, we integrated unbiased molecular docking with molecular dynamics (MD) and end-point calculations. The MD-relaxed binding mode places the trigonelline carboxylate in a polar niche stabilized by a Ser135 and Tyr150 hydrogen-bond dyad, while the pyridinium ring engages an adjacent aromatic shelf (Tyr161 and Phe130) near the His51–Asp75–Ser135 catalytic triad. The low protein RMSD and low ligand drift suggest this is a persistent pose. MM/GBSA calculated affinity is dominated by van der Waals contributions, and a per-residue decomposition highlight stabilizing roles for Ser135, Tyr150, and Pro132, consistent with the observed contact pattern and supportive of target engagement. While the potency is moderate, it is consistent with a fragment-like chemotype in the protease substrate-binding cleft and provides a tractable entry point for derivatization. Contact-persistence and the energy decomposition suggest promising avenues for future structure–activity exploration, i.e., extension of the ligand into the S1/S2 subsites, reinforcement of aromatic contacts, and polarity management to increase hydrophobic collapse as a new opportunity for dengue protease inhibitor design.
- 27 May 2022
- Published by Springer Nature in Pharmaceutical Chemistry Journal
- Vol. 56 (3) , 387-395
Physicochemical and Bioassay Directed GC-MS Analyses of Chloroform Extract of Pteris cretica L.
- 27 May 2022
- Published by Springer Nature in Pharmaceutical Chemistry Journal
- Vol. 56 (3) , 387-395
Physicochemical and Bioassay Directed GC-MS Analyses of Chloroform Extract of Pteris cretica L.
- Open Access
Isolation of Antidiabetic Withanolides from Withania coagulans Dunal and Their In Vitro and In Silico Validation
Withania coagulans (W. coagulans) is well-known in herbal medicinal systems for its high biological potential. Different parts of the plant are used against insomnia, liver complications, asthma, and biliousness, as well as it is reported to be sedative, emetic, diuretic, antidiabetic antimicrobial, anti-inflammatory, antitumor, hepatoprotective, antihyperglycemic, cardiovascular, immuno-suppressive and central nervous system depressant. Withanolides present in W. coagulans have attracted an immense interest in the scientific field due to their diverse therapeutic applications. The current study deals with chemical and biological evaluation of chloroform, and n-butanol fractions of W. coagulans. The activity-guided fractionation of both extracts via multiple chromatographic steps and structure elucidation of pure isolates using spectroscopies (NMR, mass spectrometry, FTIR and UV-Vis) led to the identification of a new withanolide glycoside, withacogulanoside-B (1) from n-butanol extract and five known withanolides from chloroform extract [withanolid J (2), coagulin E (3), withaperuvin C (4), 27-hydroxywithanolide I (5), and ajugin E (6)]. Among the tested compounds, compound 5 was the most potent α-glucosidase inhibitor with IC50 = 66.7 ± 3.6 µM, followed by compound 4 (IC50: 407 ± 4.5 µM) and compound 2 (IC50: 683 ± 0.94 µM), while no antiglycation activity was observed with the six isolated compounds. Molecular docking was used to predict the binding potential and binding site interactions of these compounds as α-glucosidase inhibitors. Consequently, this study provides basis to discover specific antidiabetic compounds from W. coagulans.
Open AccessIsolation of Antidiabetic Withanolides from Withania coagulans Dunal and Their In Vitro and In Silico Validation
Withania coagulans (W. coagulans) is well-known in herbal medicinal systems for its high biological potential. Different parts of the plant are used against insomnia, liver complications, asthma, and biliousness, as well as it is reported to be sedative, emetic, diuretic, antidiabetic antimicrobial, anti-inflammatory, antitumor, hepatoprotective, antihyperglycemic, cardiovascular, immuno-suppressive and central nervous system depressant. Withanolides present in W. coagulans have attracted an immense interest in the scientific field due to their diverse therapeutic applications. The current study deals with chemical and biological evaluation of chloroform, and n-butanol fractions of W. coagulans. The activity-guided fractionation of both extracts via multiple chromatographic steps and structure elucidation of pure isolates using spectroscopies (NMR, mass spectrometry, FTIR and UV-Vis) led to the identification of a new withanolide glycoside, withacogulanoside-B (1) from n-butanol extract and five known withanolides from chloroform extract [withanolid J (2), coagulin E (3), withaperuvin C (4), 27-hydroxywithanolide I (5), and ajugin E (6)]. Among the tested compounds, compound 5 was the most potent α-glucosidase inhibitor with IC50 = 66.7 ± 3.6 µM, followed by compound 4 (IC50: 407 ± 4.5 µM) and compound 2 (IC50: 683 ± 0.94 µM), while no antiglycation activity was observed with the six isolated compounds. Molecular docking was used to predict the binding potential and binding site interactions of these compounds as α-glucosidase inhibitors. Consequently, this study provides basis to discover specific antidiabetic compounds from W. coagulans.